Yuyu Pharma (000220.KS) Earnings Analysis
Yuyu Pharma (000220.KS) has no confirmed upcoming earnings date. Trailing P/E 6.95.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does 000220.KS next report earnings?
No confirmed upcoming earnings date is currently scheduled for 000220.KS. This page updates as the calendar is published.
000220.KS earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2024-12-31 | -45.42967 KRW | n/a | n/a | n/a |
| 2024-09-30 | 187.7 KRW | n/a | n/a | n/a |
000220.KS valuation and analyst view
| Trailing P/E | 6.95 |
|---|---|
| Trailing EPS | 574.83 KRW |
| Price / book | 0.44 |
| Dividend yield | 3.14% |
| Market cap | 56.69B |
Limited or no published sell-side analyst coverage for this symbol.
Related research pages
Frequently asked questions
When is Yuyu Pharma (000220.KS)'s next earnings date?
No confirmed upcoming earnings date is currently scheduled for 000220.KS. This page updates as the calendar is published.
Did 000220.KS beat earnings last quarter?
Consensus estimate data was not available for 000220.KS's 2024-12-31 report.
What is 000220.KS's current P/E ratio and EPS?
000220.KS trades at a trailing P/E of 6.95 on trailing EPS of 574.8316745898481 KRW.
What do analysts rate 000220.KS?
000220.KS has limited or no published sell-side analyst coverage in our dataset, so no consensus rating is shown. Fundamentals and earnings history above are sourced from company filings via FMP.